Pharma Contract Manufacturing Organization (CMO) Services in Tanzania

Tanzania’s pharmaceutical sector is steadily expanding, driven by population growth, increased healthcare access, and a rising burden of communicable and non-communicable diseases. While more than 70% of medicines are still imported, the government’s Industrialization Agenda and Third Five-Year Development Plan (FYDP III) aim to boost local drug production. This creates a growing role for Contract Manufacturing Organizations (CMOs) in helping the country achieve self-reliance and strengthen supply chain security.

Pharmaceutical Manufacturing Landscape in Tanzania

  • Import Dependency: The majority of finished medicines are imported from India, China, and Europe.
  • Government Push: The Tanzanian government targets 50% local production by 2025, positioning CMOs as vital partners.
  • Regulation: The Tanzania Medicines and Medical Devices Authority (TMDA) regulates manufacturers, product approvals, and Good Manufacturing Practices (GMP). TMDA’s standards are increasingly aligned with global benchmarks, supporting investor confidence.

Key Types of CMO Services in Tanzania

  • Solid Oral Dosages: Tablets, capsules, and caplets.
  • Liquid Dosages: Syrups, suspensions, and oral solutions.
  • Semi-Solids: Creams, ointments, and gels.
  • Small-Volume Parenterals (SVPs): Basic injectables such as antibiotics and analgesics.
  • Repackaging & Labeling: Localized packaging services for imported bulk medicines.
  • Quality Control & Testing: In-house labs at most facilities, with selective third-party testing.

Note: API manufacturing is almost non-existent in Tanzania. Most raw materials are imported, mainly from Asia.

Key Players in Tanzania’s CMO Landscape

  • Amber Lifesciences Pvt. Ltd. – WHO-GMP and ISO-certified global CMO from India; offers contract manufacturing, regulatory support, packaging, and export solutions for Tanzania.
  • Shelys Pharmaceuticals (Aspen Group) – Tanzania-based, WHO-GMP certified; produces own brands and offers contract manufacturing for large tenders.
  • Tanzania Pharmaceutical Industries (TPI) – State-owned; focuses on essential medicines for government programs.
  • Keko Pharmaceutical Industries Ltd – WHO-GMP certified; produces tablets, capsules, and liquids; potential CMO partner.

Opportunities for Companies Seeking CMO Services

  • Market Access: Local manufacturing improves chances of winning EAC (East African Community) contracts.
  • Government & Donor Tenders: Localized production often receives preference from USAID, Global Fund, and WHO programs.
  • Supply Chain Security: Reduces risk of stockouts linked to import delays.
  • Cost Efficiency: Lower logistics costs for regional distribution.
  • Reputation & CSR: Partnering in Tanzania strengthens brand reputation while contributing to Africa’s healthcare resilience.

Challenges in the Tanzanian CMO Sector

  • Limited WHO-GMP Facilities: Few plants meet global certification standards.
  • Regulatory Delays: Product approvals by TMDA may take time.
  • Raw Material Dependency: APIs and excipients are mostly imported, causing delays during customs clearance.
  • Infrastructure Gaps: Power instability and logistics inefficiencies remain concerns.
  • Intellectual Property Risks: Strong contracts and NDAs are essential for protecting formulations.

How to Select the Right CMO Partner in Tanzania

  • Conduct Audits: Verify TMDA licenses and WHO-GMP status.
  • Define Scope Clearly: From full manufacturing to only repackaging or QC testing.
  • Evaluate Capabilities: Ensure technology matches your dosage and packaging needs.
  • Negotiate Quality Agreements: Protects both regulatory and commercial interests.
  • Check Supply Chain Reliability: Confirm sourcing strategies and backup options.
  • Leverage Local Experts: Use consultants or legal advisors familiar with Tanzanian pharma regulations.

Why Choose Amber Lifesciences Pvt. Ltd. for CMO Services in Tanzania?

Amber Lifesciences Pvt. Ltd. is a WHO-GMP and ISO-certified Contract Manufacturing Organization (CMO), offering high-quality, reliable, and cost-effective pharmaceutical services for partners entering the Tanzanian and East African markets.

Key Advantages:

  • Regulatory Expertise: Support with TMDA approvals and EAC market entry.
  • Diverse Capabilities: Manufacturing of APIs and finished dosage forms across solids, liquids, injectables, and topical products.
  • Global Standards: Compliance with WHO-GMP, EU-GMP, and USFDA norms.
  • Reliable Exports: Strong logistics and supply chain networks to Tanzania and neighboring EAC countries.
  • Customized Solutions: From full-scale manufacturing to toll manufacturing, labeling, and packaging.

By partnering with Amber Lifesciences, companies can minimize risks, accelerate market entry, and ensure regulatory compliance while expanding their footprint in East Africa.

Conclusion

Tanzania’s pharmaceutical industry is at a turning point, with strong government backing and increasing demand for locally manufactured medicines. While challenges exist in infrastructure, regulation, and raw material sourcing, the opportunities for contract manufacturing are significant.

For businesses seeking a reliable partner, Amber Lifesciences Pvt. Ltd. offers the global expertise, regulatory knowledge, and flexible Contract Manufacturing Organization (CMO) solutions required to succeed in Tanzania’s evolving pharmaceutical landscape.